key: cord-0748395-rvdkkr6i authors: Alvarez, Mario Moises; Gonzalez-Gonzalez, Everardo; Trujillo-de Santiago, Grissel title: Modeling COVID-19 epidemics in an Excel spreadsheet: Democratizing the access to first-hand accurate predictions of epidemic outbreaks date: 2020-03-27 journal: nan DOI: 10.1101/2020.03.23.20041590 sha: 87591fa3e8ee53f63d931a69f0e936b7ee15e5c2 doc_id: 748395 cord_uid: rvdkkr6i COVID-19, the first pandemic of this decade and the second in less than 15 years, has harshly taught us that viral diseases do not recognize boundaries; however, they truly do discriminate between aggressive and mediocre containment responses. We present a simple epidemiological model that is amenable to implementation in Excel spreadsheets and sufficiently accurate to reproduce observed data on the evolution of the COVID-19 pandemics in different regions (i.e., Italy, Spain, and New York City (NYC)). We also show that the model can be adapted to closely follow the evolution of COVID-19 in any large city by simply adjusting two parameters related to (a) population density and (b) aggressiveness of the response from a society/government to epidemics. Moreover, we show that this simple epidemiological simulator can be used to assess the efficacy of the response of a government/society to an outbreak. Here, we construct a very simple epidemiological model for the propagation of in urban areas. The model is based on a set of differential equations. The first equation of the set (equation 1) states that the rate of accumulation of infected habitants in an urban area (assumed to be a closed system) is given by the sum of the number of new infections (positive contribution), the number of recovered patients (negative contribution), and the number of deaths (negative contribution). A second differential equation states that the rate of accumulation of the infected but asymptotic population is proportional to the population of infected and symptomatic subjects (equation 2). Two additional equations relate the number of deaths and recovered patients with the number of newly infected ones (equation 3 and 4) . Finally, the rate of depletion of the pool of the population susceptible to infection is given by the sum of recovered patients, asymptomatic infected, and deaths (equation 5). SARS and MERS epidemiology and the limited evidence on the nature of the host immune response to SARS-COV-2, we assume here that recovered patients become immune to reinfection. dX s /dt = R Infected-s -R Recovered -R Death Equation (1) dX as /dt = R Infected-as = (1/0.4) * R Infected-s Equation (2) dD/dt = R Death = 0.023 * R Infected-s Equation (3) dR/dt = R Recovered = 0.977 * R Infected-s Equation (4) dP s /dt = -R Infected-as -R Recovered -R Death Equation (5) This system is equivalent to: dX s /dt = R Infected-s -R Recovered -R Death Equation (1) where: R . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 27, 2020. . This model correctly describes the evolution of the number of newly infected during the initial stage of the epidemic episode. For later times, the rate of new infections is corrected by a term that depends on the demographic density (Dd) of the region. Therefore: Equation (7) In equation (7) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 27, 2020. . https://doi.org/10.1101/2020.03.23.20041590 doi: medRxiv preprint The number of asymptomatic inhabitants was calculated under the assumption that only 28.5% of the infected population develops symptomatology. This assumption should be regarded as arbitrary, since no reliable information specific for the ration between symptomatic and asymptomatic COVID-19 patients is available at this point. Our assumption of the distribution between symptomatic and asymptomatic patients was inspired by the high number of asymptomatic infected subjects estimated for other pandemic events. For instance, in the context of pandemic influenza A/H1N1/2009, up to 20-40% of the population in urban areas (i.e., Monterrey, México, and Pittsburgh, USA) [16, 17] exhibited specific antibodies regardless of experiencing symptoms. In addition, the average time of sickness was set at 14 days in our simulations, within the range reported from 14 to 32 days [18] , with a median time to recovery of 21 days [19] . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 27, 2020. . https://doi.org/10.1101/2020.03.23.20041590 doi: medRxiv preprint Figure 1A shows the progression on the number of COVID-19 positive cases in different regions, namely Spain (mainly Madrid), Iran (mainly Tehran), and New York City. We have selected these three data sets to illustrate that the evolution of the epidemic has a local flavor that mainly depends on the number of initial infected persons, the demographic density, and the set of containment measures taken by government officials and society. During the exponential phase, a straight line should be observed, and the slope of that line denotes the specific rate (µ) of the epidemic spreading. Note that COVID-19 has exhibited a wide range of spreading rates in different countries (from ~0.3 to ~0.9 day -1 ). Note also that µ is related to the doubling time (t d ), often reported in population and epidemiological studies, by the equation t d =Ln 2/ µ. Therefore, ranges of doubling times between 0.75 and 2.45 days are observed just among these three regional cases. Different exponential stages, perfectly distinguishable by their exhibition of different slopes, may be observed within the same time series. For instance, the outbreak in New York City ( Figure 1B ; blue symbols) was first described by an extremely high slope (µ o = 0.926 day -1 ). However, after a series of measures adopted in New York City by the federal, state, and local governments, the specific growth rate of the epidemics fell to µ = 0.308 day -1 . The last point is extremely important, since two drastically different slopes can be observed before and after a package of adequate measures within the same territory. In addition, two localities that experienced similar initial specific epidemic rates may exhibit dramatically different evolutions as a function of the initial response of government and society ( Figure 1C,D) . For instance, while the COVID-19 epidemics in Italy and South Korea exhibited practically equal µ o values, the Italian outbreak has maintained the same growth rate throughout 20 days, while South Korea has set an example by effectively and rapidly lowering the specific epidemic rate to nearly 0 in just two weeks. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 27, 2020. . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 27, 2020. . https://doi.org/10.1101/2020.03.23.20041590 doi: medRxiv preprint We have run different scenarios to validate the predictive capabilities of our epidemic model for COVID-19. Overall, the model is capable of closely reproducing the progression of reported cases for urban areas of more than 5 × 10 6 inhabitants (i.e., Iran, the city of Tehran in Iran, Spain, and New York City). We found that, adapting the model to a . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 27, 2020. . We used a set of differential equations, recent epidemiological data regarding the evolution of COVID-19 infection in a reduced set of regions (i.e., Spain, Iran, and New York City), and basic information on the characteristics of COVID-19 infection (i.e., time from infection to recovery, case mortality rate) to accurately recreate the onset of the COVID-19 in two urban areas with different demographic characteristics (i.e., New York City and Monterrey, México). We showed that the model can be adapted to closely follow the evolution of COVID-19 in densely populated urban areas by simply adjusting two parameters related to (a) population density and (b) aggressiveness of the response from a society/government to epidemics. Scenarios such as those currently unfolding in Iran, Italy, or Spain emphasize the importance of planning ahead during epidemic events. The availability of a simple model may be highly enabling for local governments, physicians, civil organizations, and citizens as they struggle in their endeavor to accurately forecast the progression of an epidemic and formulate a plan of action. As previously stated, the use of simple/user-friendly models to evaluate in (practically) real time the effectiveness of containment strategies or programs may be highly a powerful tool for analyzing and facing epidemic events [11] . This . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 27, 2020. . https://doi.org/10.1101/2020.03.23.20041590 doi: medRxiv preprint contribution shows the prediction potential of an extremely simple simulation tool that can be used by practically any citizen with basic training in Excel. For instance, using this simple model, virtually any student could assess, in real time, the efficacy of the actions of her/his society in the face of an outbreak. First Case of 2019 Novel Coronavirus in the United States Global spread of COVID-19 and pandemic potential Estimating the reproductive number and the outbreak size of Novel Coronavirus disease (COVID-19) using mathematical model in Republic of Korea COVID-19 in Singapore-Current Experience: Critical Global Issues That Require Attention and Action Epidemic analysis of COVID-19 in China by dynamical modeling Early dynamics of transmission and control of COVID-19: a (COVID-19) Infection: Inference Using Exported Cases Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19 How Modelling Can Enhance the Analysis of Imperfect Epidemic Data Reinfection could not occur in SARS-CoV-2 infected rhesus macaques Allergy and Immunology Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic Two-Year Prospective Study of the Humoral Immune Response of Patients with Severe Acute Respiratory Syndrome A pneumonia outbreak associated with a new coronavirus of probable bat origin Seroprevalence of antibodies to influenza A/H1N1/2009 among transmission risk groups after the second wave in Mexico, by a virus-free ELISA method Seroprevalence Following the Second Wave of Pandemic Positive RT-PCR Test Results in Patients Recovered From COVID-19 Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected MMA, EGG, and GTdS acknowledge the funding received from CONACyT (Consejo Nacional de Ciencia y Tecnología, México).